Monoclonal Antibodies (Casirivimab/Imdevimab and Bamlanivimab) are among the most promising COVID-19 treatements as of December 2020
FDA Emergency Use Indications include Confirmed positive COVID-19 testing AND High Risk Patients for Serious Complications
Contraindications include patient NOT hospitalized for COVID-19 AND not requiring Supplemental Oxygen for COVID-19; Thank you to Dr. Joe Weidner for email feedback
In-depth review of Cervical Myelopathy, a condition with both UMN deficits and LMN deficits
Also added associated abnormal reflexes, some of which I was surprised were still absent after FPNx20 years (e.g. Babinski Reflex, Ankle Clonus, Romberg Test)